- 1601. Interleukin Therapy
- (UMLS (NCI) C0281177) =Therapeutic or Preventive Procedure
| - 1651. Intermediate Grade Lesion
- (UMLS (NCI) C1334215) =Finding
|
- 1602. Interleukin-1 Receptor-Associated Kinase 1
- [Encoded by human IRAK1 Gene (Pelle Ser/Thr Kinase Family), ubiquitous 712-aa 77-kDa Interleukin-1 Receptor-Associated Kinase 1 is one of two putative Ser/Thr kinases that rapidly associate with the Interleukin-1 Receptor (IL1R) upon stimulation. IRAK phosphorylation occurs after association with IL1-R-1, which may activate the kinase. Found in a complex containing TRAF6, PELI1 and IRAK4, IRAK1 interacts with PELI2 and PELI3. IRAK1 is partially responsible for IL1-induced upregulation of the transcription factor NF-kappa B. (NCI) ( NCI )] (UMLS (NCI) C1334201) IRAK1;
IRAK-1;
Pelle Homolog;
=Amino Acid, Peptide, or Protein; Enzyme; Immunologic Factor | - 1652. Intermediate Grade Lymphoma
- [Includes diffuse, small, cleaved cell lymphoma and diffuse, large, noncleaved cell lymphoma. These are more aggressive than low-grade lymphomas, but they respond better to anticancer drugs. ( NCI )] (UMLS (NCI) C0079741) =Neoplastic Process =Lymphoma, Non-Hodgkin;
=Lymphoma, Non-Hodgkin;
Diffuse Large B-Cell Lymphoma;
Follicular Large Cell Lymphoma;
Diffuse Mixed Cell Lymphoma |
- 1603. Interleukin-1 Receptor-Associated Kinase 1 Gene
- [This gene plays a role in signal transduction and the immune response. ( NCI )] (UMLS (NCI) C1334134) IRAK1;
IRAK1 Gene =Gene or Genome ;
| - 1653. Intermediate Grade Malignant Neoplasm
- (UMLS (NCI) C1334216) =Neoplastic Process
|
- 1604. Interleukin-1 Receptor-Associated Kinase 2
- [Expressed in spleen, thymus, prostate, lung, liver, skeletal muscle, kidney, pancreas, and peripheral leukocytes by human IRAK2 Gene (Pelle Ser/Thr Kinase Family), 590-aa 65-kDa Interleukin-1 Receptor-Associated Kinase 2 is one of two putative Ser/Thr kinases that rapidly associate with the Interleukin-1 Receptor (IL1R) upon stimulation. IRAK2 interacts with TRAF6 and is required for IL1R-induced NF-Kappa-B activation. (NCI) ( NCI )] (UMLS (NCI) C0663246) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 1654. Intermediate Immature Teratoma
- (UMLS (NCI) C0334522) =Neoplastic Process
|
- 1605. Interleukin-1 Receptor-Associated Kinase 2 Gene
- [This gene is involved in the immune response and signal transduction. ( NCI )] (UMLS (NCI) C1334135) IRAK2;
IRAK2 Gene =Gene or Genome ;
| - 1655. Intermediate lesions of pinta
- [ ] (UMLS (ICD9CM) C0153242) =Disease or Syndrome
|
- 1606. Interleukin-1 Receptor-Associated Kinase 3
- [Expressed in peripheral leukocytes and monocytes by human IRAK3 Gene, 596-aa Interleukin-1 Receptor-Associated Kinase 3 contains an N-terminal death domain and central kinase domain. IRAK3 appears to activate NF-kappa-B via IL1R. IRAK3 interacts with MYD88 and TRAF6 signaling proteins in a manner similar to the other IRAKs. It prevents dissociation of IRAK and IRAK4 from MYD88 and formation of IRAK/TRAF6 complexes. But IRAK3 does not autophosphorylate in the manner of IRAK1. IRAK1, -2, and -3 mediate the TLR2-dependent response to lipopolysaccharide. IRAK3 is induced upon TLR stimulation and negatively regulates TLR signaling. (NCI) ( NCI )] (UMLS (NCI) C1334202) Interleukin-1 Receptor-Associated Kinase M;
IRAK3;
IRAKM;
=Amino Acid, Peptide, or Protein; Enzyme ;
| - 1656. Intermediate Lipomatous Neoplasm
- [A lipomatous neoplasm characterized by a high risk of local recurrence and no risk of metastasis. ( NCI )] (UMLS (NCI) C1334217) =Neoplastic Process
|
- 1607. Interleukin-1 Receptor-Associated Kinase 3 Gene
- [This gene is involved in signal transduction and the immune response. ( NCI )] (UMLS (NCI) C1334136) IRAK3;
IRAK3 Gene =Gene or Genome ;
| - 1657. Intermediate Mesoderm
- (UMLS (NCI) C1284010) =Embryonic Structure
|
- 1608. Interleukin-1 Receptor-Associated Kinase 4
- [Widely expressed (strongest in kidney and liver) by human IRAK4 Gene, 460-aa Interleukin-1 Receptor-Associated Kinase 4 contains (like IRAK1, IRAK2, IRAKM, and Pelle) an N-terminal death domain and a central kinase domain. Similar to Pelle, IRAK4 has a short C-terminal domain. Like all IL1R-associated kinases, IRAK4 mediates Toll/IL1R family receptor signal transduction. Like IRAK1 and Pelle, IRAK4 has auto- and cross-phosphorylation activity. IRAK4 phosphorylates and activates IRAK1. It also interacts with MYD88 and TRAF6 and activates MAPK and NF kappa-B pathways. IRAK4 may act as an IRAK1 kinase, triggering phosphorylation cascades. (NCI) ( NCI )] (UMLS (NCI) C1334203) IRAK4;
REN64 =Amino Acid, Peptide, or Protein; Enzyme ;
| - 1658. Intermediate Risk Colorectal Gastrointestinal Stromal Tumor
- (UMLS (NCI) C1334219) =Neoplastic Process
|
- 1609. Interleukin-1 Receptor-Associated Kinase 4 Gene
- [This gene plays a role in signal transduction and the immune response. ( NCI )] (UMLS (NCI) C1334137) IRAK4;
IRAK4 Gene;
=Gene or Genome ;
| - 1659. Intermediate Risk Esophageal Gastrointestinal Stromal Tumor
- (UMLS (NCI) C1334220) Intermediate Risk Esophageal GIST =Neoplastic Process
|
- 1610. Interleukin-12/MART-1 Antigen/Montanide ISA-51
- (UMLS (NCI) C0879330) =Therapeutic or Preventive Procedure
| - 1660. Intermediate Risk Gastric Gastrointestinal Stromal Tumor
- (UMLS (NCI) C1334221) Intermediate Risk Gastric GIST =Neoplastic Process
|
- 1611. Interleukin-12/Montanide ISA-51/Tyrosinase Peptide
- (UMLS (NCI) C0879316) =Therapeutic or Preventive Procedure
| - 1661. Intermediate Risk Gastrointestinal Stromal Tumor
- (UMLS (NCI) C1334222) Intermediate Risk GIST;
IR GIST;
=Neoplastic Process |
- 1612. Interleukin-12/Montanide ISA-51/Tyrosinase Related Protein-1
- (UMLS (NCI) C0879322) Interleukin-12/Montanide ISA-51/Tyrosinase-Related Protein-1 =Therapeutic or Preventive Procedure
| - 1662. Intermediate Risk Small Intestinal Gastrointestinal Stromal Tumor
- (UMLS (NCI) C1334223) Intermediate Risk Small Intestinal GIST =Neoplastic Process
|
- 1613. Interleukin-12/Paclitaxel
- (UMLS (NCI) C1327862) =Therapeutic or Preventive Procedure
| - 1663. Intermediate Soft Tissue Neoplasm
- (UMLS (NCI) C1334224) =Neoplastic Process
|
- 1614. Interleukin-12/Paclitaxel/Trastuzumab
- (UMLS (NCI) C1134712) =Therapeutic or Preventive Procedure
| - 1664. Intermediate Uveitis
- [Inflammation of the pars plana, ciliary body, and adjacent structures. ( MSH )] (UMLS (NCI) C0042166) =Disease or Syndrome =uveitis;
=PARS PLANITIS;
|
- 1615. Interleukin-12/PSA Prostate Cancer Vaccine
- (UMLS (NCI) C0935836) =Therapeutic or Preventive Procedure
| - 1665. Intermediate Vascular Neoplasm
- [A vascular neoplasm with borderline malignant potential. ( NCI )] (UMLS (NCI) C1334225) Intermediate Vascular Tumor =Neoplastic Process
|
- 1616. Interleukin-12/Rituximab
- (UMLS (NCI) C0879417) =Therapeutic or Preventive Procedure
| - 1666. Intermediate. Indicates for microbiology susceptibilities only.
- (UMLS (HL7) C1548137) =Qualitative Concept =Abnormal flags;
|
- 1617. Interleukin-2 Liposome
- [A formulation in which liposomes are loaded with the cytokine interleukin-2 (IL-2). By activating cytotoxic T-lymphocytes, such as lymphokine-activated killer cells, and increasing levels of the cytotoxic cytokines interferon-gamma (IFN-gamma) and transforming growth factor-beta (TGF-beta), IL-2 may exhibit antitumoral activity. Liposomal formulations of IL-2 may promote entry of the cytokine into target tumor cells and may be used as an immunoadjuvant in cancer vaccine therapy. (NCI04) ( NCI )] (UMLS (NCI) C0281031) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 1667. Intermembrane Space of the Mitochondrion
- [The region between the inner and outer lipid bilayers of the mitochondrial envelope. [GOC:mah] ( GO )] (UMLS (NCI) C1166886) =Cell Component
|
- 1618. Interleukin-2/interleukin-12
- (UMLS (NCI) C0879476) =Therapeutic or Preventive Procedure ;
| - 1668. Intermenstrual bleeding
- [Abnormal uterine bleeding that is not related to MENSTRUATION, usually in females without regular MENSTRUAL CYCLE. The irregular and unpredictable bleeding usually comes from a dysfunctional ENDOMETRIUM.(MSH)] (UMLS (ICPC) C0025874) (Intermenstrual bleeding; HILEROKOARTEKO ODOLJARIOA ETA ZIKLOKO BESTE ZENBAIT NAHASTE; Intermenst blodn og an cyklusforst; Intermenstrueel bloedverlies; VALIVUOTO; Saignement intermenstruel; intermenstruelle Blutung; veset - hafraot/i sdirut; kozti verzes; Sanguinamento intermestruale; INTERMENSTRUELL BLODNING - n92.3 + n93.R; Hemorragia inter-menstrual; Hemorragia intermenstrual; INTERMENSTRUELL BLODNING) =Pathologic Function =Uterine Hemorrhage; FEMALE GENITAL SYSTEM (INCLUDING BREAST); Symptoms and Complaints Component;
|
- 1619. Interleukin-2/Isotretinoin/Monoclonal Antibody Ch14.18
- (UMLS (NCI) C1134513) =Therapeutic or Preventive Procedure
| - 1669. Intermenstrual pain
- (UMLS (ICPC) C0152149) (Intermenstrual pain; HILEROKOARTEKO MINA; Smerte mellem menstruationer; Intermenstruele pijn; KUUKAUTISTEN VALILLA ESIINTYVAT KIVUT; Douleur intermenstruelle; Schmerzen zwischen Menstruationen; (108); kozti fajdalom; Dolore intermestruale; INTERMENSTRUELLE SMERTER n94.0; Dor intermenstrual; Dolor intermenstrual; SMARTA MELLAN MENSTRUATIONER) =Sign or Symptom =FEMALE GENITAL SYSTEM (INCLUDING BREAST); Symptoms and Complaints Component
|
- 1620. Interleukin-2/MAGE-12 Peptide Vaccine/Montanide ISA-51
- (UMLS (NCI) C0935672) =Therapeutic or Preventive Procedure
| - 1670. INTERMIT ALTRN ESOTROPIA
- [ ] (UMLS (ICD9CM) C0152212) =Disease or Syndrome ;
|
- 1621. Interleukin-2/Monoclonal Antibody Ch14.18
- (UMLS (NCI) C0935880) =Therapeutic or Preventive Procedure
| - 1671. INTERMIT ALTRN EXOTROPIA
- [ ] (UMLS (ICD9CM) C0152214) =Disease or Syndrome ;
|
- 1622. Interleukin-2/Montanide ISA-51/Telomerase: 540-548 Peptide Vaccine
- (UMLS (NCI) C0935897) =Therapeutic or Preventive Procedure
| - 1672. INTERMIT ANGL-CLOS GLAUC
- [ ] (UMLS (ICD9CM) C0154945) =Disease or Syndrome ;
|
- 1623. Interleukin-2/Montanide ISA-51/Tyrosinase Peptide
- (UMLS (NCI) C0879315) =Therapeutic or Preventive Procedure
| - 1673. INTERMIT HETEROTROP NOS
- [ ] (UMLS (ICD9CM) C0152210) =Disease or Syndrome ;
|
- 1624. Interleukin-2/Montanide ISA-51/Tyrosinase-Related Protein-1
- (UMLS (NCI) C0879321) =Therapeutic or Preventive Procedure
| - 1674. INTERMIT MONOC ESOTROPIA
- [ ] (UMLS (ICD9CM) C0152211) =Disease or Syndrome ;
|
- 1625. Interleukin-2/Montanide ISA-51/Tyrosinase-Related Protein-2
- (UMLS (NCI) C1134466) =Therapeutic or Preventive Procedure
| - 1675. INTERMIT MONOC EXOTROPIA
- [ ] (UMLS (ICD9CM) C0152213) =Disease or Syndrome ;
|
- 1626. Interleukin-2/Montanide ISA-51/Von Hippel-Lindau Peptide Vaccine
- (UMLS (NCI) C0879309) =Therapeutic or Preventive Procedure
| - 1676. INTERMITT EXPLOSIVE DIS
- (UMLS (ICD9CM) C0021776) =Mental or Behavioral Dysfunction ;
|
- 1627. Interleukin-2/p53 Peptide Vaccine
- (UMLS (NCI) C1327823) =Therapeutic or Preventive Procedure ;
| - 1677. INTERMITT SKEL TRACTION
- [ ] (UMLS (ICD9CM) C0178028) =Therapeutic or Preventive Procedure
|
- 1628. Interleukin-2/Staphylococcal Enterotoxin B
- (UMLS (NCI) C0879542) =Therapeutic or Preventive Procedure ;
| - 1678. Intermittent exophthalmos
- [ ] (UMLS (ICD9CM) C0155270) =Disease or Syndrome ;
|
- 1629. Interleukin-2/Stem Cell Factor
- (UMLS (NCI) C0879556) =Therapeutic or Preventive Procedure
| - 1679. Intermittent Fever
- (UMLS (NCI) C0277799) =Sign or Symptom
|
- 1630. Interleukin-2/Trastuzumab
- (UMLS (NCI) C0935669) =Therapeutic or Preventive Procedure
| - 1680. intermittent peritoneal dialysis
- [ ] (UMLS (CSP) C0405886) =Therapeutic or Preventive Procedure
|
- 1631. Interleukin-2/Vaccine-Sensitized Draining Lymph Node Cells
- (UMLS (NCI) C0879356) =Therapeutic or Preventive Procedure ;
| - 1681. Intermittent positive pressure breathing [IPPB]
- [Application of positive pressure to the inspiratory phase of spontaneous respiration. ( MSH )] (UMLS (ICD9CM) C0021777) =Therapeutic or Preventive Procedure ;
|
- 1632. Interleukin-2/Vaccinia-Tyrosinase Vaccine
- (UMLS (NCI) C0796659) =Therapeutic or Preventive Procedure
| - 1682. intermolecular interaction
- [ ] (UMLS (CSP) C0596788) =Spatial Concept =chemistry;
=chemical binding;
chemical association;
molecular stacking;
protein protein interaction;
|
- 1633. Interlobular Bile Duct
- (UMLS (NCI) C0227515) =Body Part, Organ, or Organ Component
| - 1683. Internal
- [Code system is created and maintained by HL7 ( HL7V3.0 )] (UMLS (HL7) C1553872) =Intellectual Product =HL7 Code System Type;
◊ [Code system is created and updated by an organization outside of HL7, but an internal copy is mainted by HL7 for convenience ( HL7V3.0 )] (UMLS (HL7) C1619620) Intellectual Product HL7 Code System Type; |
- 1634. Interlocutory
- [Subject to an Interlocutory Decree. ( HL7V3.0 )] (UMLS (HL7) C1549108) =Finding =marital status;
MaritalStatus | - 1684. Internal Anal Sphincter
- (UMLS (NCI) C0227421) =Body Part, Organ, or Organ Component
|
- 1635. Intermediary Metabolism
- [sum of chemical changes that occur within the tissues of an organism consisting of anabolism (biosynthesis) and catabolism; the buildup and breakdown of molecules for utilization by the organism. ( CSP )] (UMLS (NCI) C0025519) =Organism Function =biochemistry;
Elimination =bioenergetics;
biotransformation;
anabolism;
aerobic metabolism;
carbohydrate metabolism;
bioaccumulation;
aminoacid metabolism;
bone metabolism;
brain metabolism;
connective tissue metabolism;
heart metabolism;
hormone metabolism;
metal metabolism;
microorganism metabolism;
muscle metabolism;
neurotransmitter metabolism;
nitrogen metabolism;
nucleic acid metabolism;
Metabolism, Purines/Pyrimidines/Nucleotides/Nucleic Acids;
phosphorus metabolism;
porphyrin metabolism;
protein metabolism;
purine/pyrimidine metabolism;
toxin metabolism;
vitamin metabolism;
fat metabolism;
basal metabolism;
drug metabolism;
measurement of metabolism;
Hepatic Metabolism;
kidney metabolism;
Site of Metabolism;
Enzymatic Pathway of Metabolism;
| - 1685. Internal Auditory Artery
- (UMLS (NCI) C0226237) =Body Part, Organ, or Organ Component
|
- 1636. intermediate
- [Intermediate ( HL7V3.0 )] (UMLS (HL7) C1550465) =Idea or Concept =ObservationInterpretationSusceptibility;
| - 1686. Internal Auditory Canal Lipoma
- [A rare benign adipose tissue neoplasm of the internal auditory canal, often presenting as an acoustic tumor. It may be intermixed with the vestibulocochlear nerve and may adhere to adjacent structures. ( NCI )] (UMLS (NCI) C1334226) Internal Ear Lipoma;
Lipoma of Internal Auditory Canal;
Lipoma of the Internal Auditory Canal =Neoplastic Process |
- 1637. Intermediate Blood Vessel Neoplasm
- [A borderline blood vessel neoplasm that can be locally aggressive, and may metastasize on rare occasions. ( NCI )] (UMLS (NCI) C1334207) Intermediate Blood Vessel Tumor =Neoplastic Process; ;
| - 1687. Internal Auditory Canal Meningioma
- (UMLS (NCI) C1334227) Meningioma of Internal Auditory Canal;
Meningioma of the Internal Auditory Canal;
=Neoplastic Process |
- 1638. Intermediate Care Facility, Mentally Retarded
- [(1) A public institution for care of the mentally retarded or people with related conditions. (2) An institution giving active treatment to mentally retarded or developmentally disabled persons or persons with related conditions. The primary purpose of the institution is to provide health or rehabilitative services to such individuals.Sources: (1) Lexikon: Dictionary of Health Care Terms, Organizations and Acronyms for the Era of Reform, Joint Commission on Accreditation of Healthcare Organizations, Oakbrook Terrace, IL: 1994, p. 403 (2) Paraphrased from Code of Federal Regulations #42, Public Health, Section 440.150(c). ( HL7V3.0 )] (UMLS (HL7) C1552484) =Intellectual Product ;
=Nursing and Custodial Care Facilities;
| - 1688. Internal Capsule
- [White matter pathway, flanked by nuclear masses, consisting of both afferent and efferent fibers projecting between the cerebral cortex and the brainstem. It consists of three distinct parts: the anterior limb, posterior limb, and genu. (MeSH) ( NCI )] (UMLS (NCI) C0152341) =Body Part, Organ, or Organ Component
|
- 1639. Intermediate Care, Mental Illness
- [A nursing facility that provides an intermediate level of nursing care to individuals whose functional abilities are significantly compromise by mental illness. ( HL7V3.0 )] (UMLS (HL7) C1552539) =Intellectual Product ;
=Nursing and Custodial Care Facilities;
| - 1689. Internal Carotid Artery
- [Branch of the common carotid artery which supplies the anterior part of the brain, the eye and its appendages, the forehead and nose. ( MSH )] (UMLS (NCI) C0007276) =Body Part, Organ, or Organ Component
|
- 1640. Intermediate Cell Type Choroid Melanoma
- (UMLS (NCI) C1334208) =Neoplastic Process; ;
| - 1690. Internal Carotid Artery Branch
- (UMLS (NCI) C1182571) =Body Part, Organ, or Organ Component
|
- 1641. Intermediate Cell Type Ciliary Body Melanoma
- (UMLS (NCI) C1334209) =Neoplastic Process; ;
| - 1691. Internal Carotid Nerve Plexus
- (UMLS (NCI) C0459526) =Body Part, Organ, or Organ Component
|
- 1642. Intermediate Cell Type Intraocular Melanoma
- (UMLS (NCI) C0279693) =Neoplastic Process
| - 1692. Internal Cerebral Vein
- (UMLS (NCI) C0149579) =Body Part, Organ, or Organ Component
|
- 1643. Intermediate Cell Type Iris Melanoma
- (UMLS (NCI) C1334210) =Neoplastic Process; ;
| - 1693. internal control
- [ ] (UMLS (CSP) C0597937) =Mental Process ;
|
- 1644. Intermediate Cutaneous Fibrohistiocytic Neoplasm
- [A borderline fibrohistiocytic neoplasm arising from the dermis and extending to the subcutaneous tissues. ( NCI )] (UMLS (NCI) C1334211) =Neoplastic Process; ;
| - 1694. Internal fixation of bone without fracture reduction
- [ ] (UMLS (ICD9CM) C0185372) =Therapeutic or Preventive Procedure
|
- 1645. intermediate diagnosis
- [Intermediate diagnoses are those diagnoses documented for administrative purposes during the course of a hospital stay. ( HL7V3.0 )] (UMLS (HL7) C1555320) =Intellectual Product =ObservationDiagnosisTypes;
| - 1695. Internal fixation of femur without fracture reduction
- [ ] (UMLS (ICD9CM) C0188093) =Therapeutic or Preventive Procedure
|
- 1646. Intermediate Fibrocytic Neoplasm
- [A neoplasm of borderline malignant potential that arises from the soft tissues. It is characterized by the presence of spindle-shaped fibroblasts. ( NCI )] (UMLS (NCI) C1334212) Intermediate Fibrocytic Tumor;
Intermediate Fibrogenic Neoplasm;
Intermediate Fibrogenic Tumor;
Intermediate Fibrous Neoplasm;
Intermediate Fibrous Tumor =Neoplastic Process | - 1696. Internal fixation of patella without fracture reduction
- [ ] (UMLS (ICD9CM) C0188173) =Therapeutic or Preventive Procedure
|
- 1647. Intermediate Fibrohistiocytic Neoplasm
- [A fibrohistiocytic neoplasm usually affecting younger patients. It is characterized by an increased risk of local recurrence and a low risk of metastasis. — 2003 ( NCI )] (UMLS (NCI) C1334213) Intermediate Fibrohistiocytic Tumor =Neoplastic Process
| - 1697. Internal Geniculate Body
- [part of the diencephalon inferior to the caudal end of the dorsal thalamus which relays auditory impulses from the lateral lemniscus to the auditory cortex. ( CSP )] (UMLS (NCI) C0086596) =Body Part, Organ, or Organ Component ;
=thalamus;
|
- 1648. intermediate filament
- [cytoplasmic filament intermediate in diameter (about 10 nanometers) between the microfilaments and the microtubules; may be composed of any of a number of different proteins and form a ring around the cell nucleus. ( CSP )] (UMLS (CSP) C0021770) =Cell Component ;
=Cellular Matrix;
=neurofilament;
| - 1698. Internal Hemorrhoid
- [A hemorrhoid which originates above the dentate line. ( NCI )] (UMLS (NCI) C0265034) =Disease or Syndrome ;
|
- 1649. Intermediate Filament Gene
- [Intermediate Filament Genes encode a number of different Intermediate Filament Proteins (including keratin filaments, neurofilaments, desmin, and vimentin) that form polymeric structural cytoplasmic filaments, intermediate in diameter (8-10 nanometer) between actin microfilaments and microtubules, which comprise part of the cytoskeleton of most eukaryotic cells. (NCI) ( NCI )] (UMLS (NCI) C1334214) =Gene or Genome
| - 1699. Internal Iliac Artery
- (UMLS (NCI) C0226364) =Body Part, Organ, or Organ Component
|
- 1650. Intermediate Grade Adult Non-Hodgkin's Lymphoma
- (UMLS (NCI) C0279076) =Neoplastic Process
| - 1700. Internal Iliac Artery Branch
- (UMLS (NCI) C1282080) =Body Part, Organ, or Organ Component
|
home
